Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-angiogenic drugs

Haematologica Reports

Volumn 2, Issue 3, 2006, Pages 45-47

  Ruegg C ^a,b  

^a University of Lausanne Medical Center   (Switzerland)

^b National Center of Competence in Research in Molecular Oncology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; RAC PROTEIN; ROFECOXIB; VITRONECTIN RECEPTOR;

ANTIANGIOGENIC ACTIVITY; ARTHRITIS; CARDIOTOXICITY; CELL ADHESION; CELL MIGRATION; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; ENDOTHELIUM CELL; ENZYME INHIBITION; HEART ARREST; HEART INFARCTION; HUMAN; INTRACARDIAC THROMBOSIS; MUSCULOSKELETAL PAIN; PROTEIN EXPRESSION; SIDE EFFECT; STROKE; SUDDEN DEATH; TRANSIENT ISCHEMIC ATTACK; UMBILICAL VEIN; UNSTABLE ANGINA PECTORIS;

EID: 46749134408     PISSN: 18249337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 2002;53:35-57.
2. Ruegg C, Zaric J, Stupp R. Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality. Ann Med 2003;35:476-87.
3. Monnier Y, Zaric J, Ruegg C. Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: from the bench to the bedside and back. Curr Drug Targets Inflamm Allergy 2005;4:31-8.
4. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001;1:11-21.
5. Folkman, J. Role of angiogenesis in tumor growth and metastasis. Sem Oncol 2002;29:15-8.
6. Gately S, Li WW. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol 2004;31:2-11.
7. Dormond O, Foletti A, Paroz C, Ruegg C. NSAIDs inhibit alphaVbeta3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nat Med 2001;7:1041-7.
8. Eliceiri BP, Cheresh DA. Role of alpha V integrins during angiogenesis. Cancer J 2000;6:S245-S9.
9. Dormond O, Bezzi M, Mariotti A, Ruegg, C. Prostaglandin E2 promotes integrin alphaVbeta3-dependent endothelial cell adhesion, Rac-activation and spreading through cAMP/PKA signaling. J Biol Chem 2002;277:45838-46.
10. Zaric J, Ruegg C. Integrin-mediated adhesion and soluble ligand binding stabilize COX-2 protein levels in endothelial cells by inducing expression and preventing degradation. J Biol Chem 2005;280:1077-85.